Agape ATP's biggest risks in the FY2024 10-K
- Heavy reliance on two major suppliers representing 77.3% of total purchases in 2024 creates significant concentration risk.
The risks most specific to Agape ATP
We are exposed to concentration risk of heavy reliance on our two largest suppliers for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation
We rely heavily on our two largest suppliers, who accounted for 59.8% and 17.5% of our total purchases in 2024.
We may be unable to protect our intellectual property rights
We own only five registered trademarks in Malaysia and may fail to protect our intellectual property against counterfeiting.
We operate in a heavily regulated industry
Our products must comply with the Food Act of 1983 and regulations from the Ministry of Health in Malaysia.
We have a limited operating history in the Malaysia health and wellness industry, which makes it difficult to evaluate our future prospects
We have a limited operating history in the Malaysian health and wellness industry since launching our ATP Zeta Super Health Program in 2016.
Our lack of insurance could expose us to significant costs and business disruption
We do not carry any product liability or business disruption insurance to cover our operations in Malaysia.
Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business
Our business depends heavily on our CEO and President, Mr. How Kok Choong, and we lack key man insurance.
All 31 risk factors
Headings as the filing states them, in filing order.
Other
- 01We are exposed to concentration risk of heavy reliance on our two largest suppliers for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation
- 02Furthermore, in the event of any delay in delivery of the products to us, our cash flow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from our customers
- 03We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business
- 04If we fail to maintain quality products and value, our sales are likely to be negatively affected
- 05If we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products
- 06We may be unable to protect our intellectual property rights
- 07We may incur losses resulting from product liability claims or product recalls or adverse publicity relating to our products
- 08We operate in a heavily regulated industry
- 09Our internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public
- 10Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation
- 11Our failure to comply with anti-corruption laws and regulations, or effectively manage our employees, customers and business partners, could severely damage our reputation, and materially and adversely affect our business, financial condition, results of operations and prospects
- 12If we are unable to successfully develop and timely introduce new products or services or enhance existing products or services, our business, financial condition and results of operations may be materially and adversely affected
- 13We may not be able to manage the growth of our business and our expansion plans and operations or implement our business strategies on schedule or within our budget, or at all
- 14We have a limited operating history in the Malaysia health and wellness industry, which makes it difficult to evaluate our future prospects
- 15Our historical growth rates may not be indicative of our future growth. If we are unable to manage the growth and increased complexity of our business, fail to control our costs and expenses, or fail to execute our strategies effectively, our business and business prospects may be materially and adversely affected
- 16Our lack of insurance could expose us to significant costs and business disruption
- 17A decline in general economic condition could lead to reduced consumer demand and could negatively impact our business operation and financial condition, which in turn could have a material adverse effect on our business, financial condition and results of operations
- 18We may be adversely affected by the performance of third-party contractors
- 19We may need additional capital, and financing may not be available on terms acceptable to us, or at all
- 20Adverse developments in our existing areas of operation could adversely impact our results of business, results of operations and financial condition
- 21Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results
- 22Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business
- 23If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected
Risks Related to our Industry
- 24We operate in a highly competitive market. If we do not compete effectively, our prospects, operating results, and financial condition could be materially and adversely affected
Risks Related to Doing Business in Malaysia
- 25Developments in the social, political, regulatory and economic environment in Malaysia may have a material adverse impact on us
- 26We are subject to foreign exchange control policies in Malaysia
- 27Economic, market and political developments in the countries where we operate could have a material and adverse effect on our business
Risks Related to our Common Stock
- 28Volatility in our shares price may subject us to securities litigation
- 29We may never be able to pay dividends and are unlikely to do so
- 30Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities
- 31We are a “smaller reporting company,” and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investors
Other Agape ATP 10-Ks
- FY2025 10-K risk factors35 risks4 new4 reworded
The company added public-listing and Nasdaq compliance risks, updated financial metrics for 2025, and expanded supplier and currency exposures.
Filed Apr 13, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.